Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytokinetics (NQ: CYTK ) 56.25 -0.33 (-0.58%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 837,974 Open 56.83 Bid (Size) 56.00 (2) Ask (Size) 57.26 (1) Prev. Close 56.58 Today's Range 55.43 - 56.91 52wk Range 25.98 - 110.25 Shares Outstanding 95,640,600 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q2 2024 August 08, 2024 CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Cytokinetics' Wild Ride: Can Investors Forgive The Royalty Pharma Deal? July 11, 2024 CEO Robert Blum says there are key components to the funding arrangement with Royalty Pharma that investors are missing. Via Investor's Business Daily Performance YTD -33.13% -33.13% 1 Month -2.04% -2.04% 3 Month -5.03% -5.03% 6 Month -26.47% -26.47% 1 Year +68.62% +68.62% More News Read More 7 Biotech Stocks to Boost Your Portfolio to Peak Health June 26, 2024 Via InvestorPlace Peering Into Cytokinetics's Recent Short Interest June 07, 2024 Via Benzinga June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge June 05, 2024 Via InvestorPlace Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views May 23, 2024 Via Benzinga Topics Earnings Stocks Exposures Financial US Equities (CYTK) - Analyzing Cytokinetics's Short Interest May 01, 2024 Via Benzinga $100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today April 03, 2024 Via Benzinga Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe May 23, 2024 Via Benzinga 8 Health Care Stocks Whale Activity In Today's Session May 23, 2024 Via Benzinga Stocks Mixed Amid Flood Of Economic Data May 23, 2024 Via Talk Markets 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga Gold Falls Sharply; US Composite PMI Surges In May May 23, 2024 Via Benzinga Why Cytokinetics (CYTK) Shares Are Falling May 23, 2024 Via Benzinga Why NVIDIA Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket May 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 23, 2024 Via Benzinga NVIDIA To Rally Over 39%? Here Are 10 Top Analyst Forecasts For Thursday May 23, 2024 Via Benzinga VF Corp Posts Weak Q4 Results, Joins NetEase, Cytokinetics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session May 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session May 22, 2024 Via Benzinga Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline May 22, 2024 From Royalty Pharma plc; Cytokinetics Via GlobeNewswire 10 Health Care Stocks Whale Activity In Today's Session May 17, 2024 Via Benzinga Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day May 13, 2024 Via Investor's Business Daily CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare May 07, 2024 Via InvestorPlace 3 Biotech Stocks to Buy on the Dip: April 2024 April 26, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
